ASCO: AE37 Peptide Vaccine May Help Prevent Breast Cancer Recurrence Cancer Network By Anna Azvolinsky, PhD | June 11, 2012 Women previously treated for HER2-positive breast cancer have lower rates of relapse when given a novel peptide vaccine. The AE37 vaccine showed a 43% risk reduction in these patients after 22 months of follow-up ... |